Publications
-
Redox Active Antimicrobial Peptides in Controlling Growth of Microorganisms at Body Barriers.
Date: 2021 Mar 13
PMID: 33805777
Source: Antioxidants (Basel)
Authors: Brzoza P, Godlewska U, Borek A, Morytko A, Zegar A, Kwiecinska P, Zabel BA, Osyczka A, Kwitniewski M, Cichy J
Article ID(s): pubmed:33805777, pmc:PMC7998263, pmcid:pmc-id: PMC7998263;, doi:10.3390/antiox10030446, pii:antiox10030446
Read More -
Bacteria Modify Their Sensitivity to Chemerin-Derived Peptides by Hindering Peptide Association With the Cell Surface and Peptide Oxidation.
Date: 2020
PMID: 32849424
Source: Front Microbiol
Authors: Godlewska U, Bilska B, Majewski P, Pyza E, Zabel BA, Cichy J
Article ID(s): pubmed:32849424, pmc:PMC7431654, pmcid:pmc-id: PMC7431654;, doi:10.3389/fmicb.2020.01819
Read More -
Novel CD11b(+)Gr-1(+)Sca-1(+) myeloid cells drive mortality in bacterial infection.
Date: 2020 Jan
PMID: 32010784
Source: Sci Adv
Authors: Park MY, Kim HS, Lee HY, Zabel BA, Bae YS
Article ID(s): pubmed:32010784, pmc:PMC6976299, pmcid:pmc-id: PMC6976299;, doi:10.1126/sciadv.aax8820, pii:aax8820
Read More -
Editorial: The Role of Chemoattractants in the Tumor Microenvironment.
Date: 2019
PMID: 31781129
Source: Front Immunol
Authors: Bernardini G, Zabel BA
Article ID(s): pubmed:31781129, pmc:PMC6861414, pmcid:pmc-id: PMC6861414;, doi:10.3389/fimmu.2019.02671
Read More -
Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.
Date: 2019
PMID: 31139180
Source: Front Immunol
Authors: Pachynski RK, Wang P, Salazar N, Zheng Y, Nease L, Rosalez J, Leong WI, Virdi G, Rennier K, Shin WJ, Nguyen V, Butcher EC, Zabel BA
Article ID(s): pubmed:31139180, pmc:PMC6518384, pmcid:pmc-id: PMC6518384;, doi:10.3389/fimmu.2019.00983
Read More -
A phospholipase D2 inhibitor, CAY10594, ameliorates acetaminophen-induced acute liver injury by regulating the phosphorylated-GSK-3β/JNK axis.
Date: 2019 May 10
PMID: 31076618
Source: Sci Rep
Authors: Lee SK, Bae GH, Kim YS, Kim HS, Lee M, Ghim J, Zabel BA, Ryu SH, Bae YS
Article ID(s): pubmed:31076618, pmc:PMC6510900, pmcid:pmc-id: PMC6510900;, doi:10.1038/s41598-019-43673-x, pii:10.1038/s41598-019-43673-x
Read More -
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
Date: 2019 May 9
PMID: 31073181
Source: Sci Rep
Authors: Kumar V, LaJevic M, Pandrala M, Jacobo SA, Malhotra SV, Zabel BA
Article ID(s): pubmed:31073181, pmc:PMC6509344, pmcid:pmc-id: PMC6509344;, doi:10.1038/s41598-019-43428-8, pii:10.1038/s41598-019-43428-8
Read More -
Support of Tumor Endothelial Cells by Chemokine Receptors.
Date: 2019
PMID: 30800123
Source: Front Immunol
Authors: Salazar N, Zabel BA
Article ID(s): pubmed:30800123, pmc:PMC6375834, pmcid:pmc-id: PMC6375834;, doi:10.3389/fimmu.2019.00147
Read More -
DGAT1 inhibits retinol-dependent regulatory T cell formation and mediates autoimmune encephalomyelitis.
Date: 2019 Feb 19
PMID: 30718413
Source: Proc Natl Acad Sci U S A
Authors: Graham KL, Werner BJ, Moyer KM, Patton AK, Krois CR, Yoo HS, Tverskoy M, LaJevic M, Napoli JL, Sobel RA, Zabel BA, Butcher EC
Article ID(s): pubmed:30718413, pmc:PMC6386656, pmcid:pmc-id: PMC6386656;, doi:10.1073/pnas.1817669116, pii:1817669116
Read More -
Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention.
Date: 2018
PMID: 30555465
Source: Front Immunol
Authors: Shin WJ, Zabel BA, Pachynski RK
Article ID(s): pubmed:30555465, pmc:PMC6283908, pmcid:pmc-id: PMC6283908;, doi:10.3389/fimmu.2018.02772
Read More
|
|
|
|
